HomeAbout us Research&Development Scientific Background Investors Careers News Contact 7. November 2007 Neurotune moves to new laboratories and starts the preclinical development of initial candidate substances for the treatment of sarcopenia Press Release N° 2007/05 [Download PDF] 1. August 2007 Neurotune expands its management by taking on an expert for preclinical development and appointing a new CFO Neurotune AG has taken on Dr. Jan Willem Vrijbloed for the expansion of its preclinical development division, and has appointed Michael Kregar as the new Chief Financial Officer (CFO). Press Release N°: 2007/04 [Download PDF] 20. June 2007 Neurotune Neurotune AG is honoured on the occasion of the award ceremony „ZKB Pioneer Award TECHNOPARK® 2007“ Neurotune AG was awarded a prize for its activity in the area of developing drugs to treat age-related muscle atrophy – Sarcopenia – and other disorders of the human nervous system on Tuesday evening. Press Release N°: 2007/03 [Download PDF] May 21-22, 2007 Neurotune to present during the Next Wave Session at the BioEquity 2007, in Glasgow, Scotland. For more information, please see http://www.ebdgroup.com/bioequity/ April 23, 2007 Neurotune announces closing of 3rd Seed Financing Round Press Release N°: 2007/02 [Download PDF] April 2nd, 2007 Neurotune AG and NiKem Research Srl enter into a Research Service Agreement Press Release N°: 2007/01 [Download PDF] November 6-8, 2006 Neurotune to present at the BioEurope 2006, November 6-8, Düsseldorf, Germany. For more information, please see www.ebdgroup.com/bioeurope/ October 13, 2006 Neurotune to present at the 2nd Swiss-Scandinavian Bio-Business Seminar, October 13, 2006, Zürich, Switzerland. For more information, please see www.greaterzuricharea.ch September 19-21, 2006 Meet us at the Biobusiness Network 2006 Partnering Conference at the Hotel President Wilson, Geneva, Switzerland. For more information, please see www.biobusiness-partnering.com 26. June 2006 Neurotune announces second closing of Seed Financing Round With the conclusion of its Second Seed Round Financing Neurotune adds another CHF 2.5 Mio to its funds. Press Release N°: 2006/03 [Download PDF] May 22-23, 2006 Neurotune to present at the BioEquity Europe 2006 in Frankfurt/Main, Germany during the Next Wave presentation session on Monday, May 22. For more information, please see www.biocentury.com or www.ebdgroup.com 17. May 2006 Neurotune successfully concludes CHF 4.9 Mio. Private Equity Financing Round Second Seed Round Financing through Private Equity and Loan from Existing and New Investors. Press Release N°: 2006/02[Download PDF] 6. Februar 2006 Neurotune appoints new CEO Dr. Andreas J. Schulze is new CEO of Neurotune AG. Press Release N°: 2006/01 [Download PDF] © Copyright by Neurotune Switzerland